AlzeCure Pharma Secures a $2.2B QuantumCell Deal for Its NeuroRestore Platform
AlzeCure Pharma has found a partner for its Alzheimer’s program, and the numbers attached to the deal are eye-catching, though not all of them in…
AlzeCure Pharma has found a partner for its Alzheimer’s program, and the numbers attached to the deal are eye-catching, though not all of them in…
